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Abstract. Ischemia-reperfusion (I/R) injury is a common occurrence in liver surgery. In orthotopic transplantation,
the donor liver is exposed to periods of ischemia and when oxygenated blood is reintroduced to the liver, oxidative
stress may develop and lead to graft failure. The aim of this project was to investigate whether noninvasive
multiphoton and fluorescence lifetime imaging microscopy, without external markers, were useful in detecting
early liver damage caused by I/R injury. Localized hepatic ischemia was induced in rats for 1 h followed by 4 h
reperfusion. Multiphoton and fluorescence lifetime imaging microscopy was conducted prior to ischemia and up
to 4 h of reperfusion and compared to morphological and biochemical assessment of liver damage. Liver function
was significantly impaired at 2 and 4 h of reperfusion. Multiphoton microscopy detected liver damage at 1 h of
reperfusion, manifested by vacuolated cells and heterogeneous spread of damage over the liver. The damage was
mainly localized in the midzonal region of the liver acinus. In addition, fluorescence lifetime imaging showed
a decrease in cellular metabolic activity. Multiphoton and fluorescence lifetime imaging microscopy detected
evidence of early I/R injury both structurally and functionally. This provides a simple noninvasive technique useful
for following progressive liver injury without external markers. C©2011 Society of Photo-Optical Instrumentation Engineers (SPIE).
[DOI: 10.1117/1.3647597]
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1 Introduction
Ischemia-reperfusion (I/R) injury of the liver is a common phe-
nomenon and a major cause of morbidity and mortality in
many clinical situations, including hepatic resection and liver
transplantation.1, 2 Cellular damage in I/R injury is intensified
when the transplanted liver is reperfused with blood after pro-
longed period(s) of ischemia in the donated liver.3 During or-
thotopic liver transplantation, oxygenated blood is reintroduced
to the liver resulting in oxidative stress through free radical
production.4 Hepatic injury in the transplanted liver results in
intracellular adenosine triphosphate (ATP) loss, increased mi-
crovascular permeability, inflammatory cell infiltration, and po-
tentially, cell death in the forms of apoptosis and necrosis.5, 6
As a consequence, oxidative stress may lead to graft failure and
rejection of the transplanted liver.6
The reduced form of nicotinamide adenine dinucleotide
(NADH) is essential in the production of ATP as an electron
donor and a coenzyme.7–9 ATP can be produced in two ways:
1. through glycolysis, an anaerobic process occurring in the cy-
toplasm; or 2. through oxidative phosphorylation, an aerobic
process occurring in the mitochondria.8 NADH can be free or
protein-bound where binding occurs to a mitochondrial mem-
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brane protein, which mediates electron transfer from NADH to
oxygen and results in H+ being transported to the cytoplasm.
This yields a gradient that is necessary for ATP synthesis and
occurs only in the presence of oxygen.9 Thus, bound NADH is
involved in ATP synthesis in aerobic conditions.9 The free form
of NADH is mainly located in the cytoplasm, where glycolysis
occurs, producing ATP without oxygen.10 Accordingly, free and
protein-bound NADH are involved in the production of ATP and
changes in the ratio between the two forms gives insight into
the metabolic state of a cell.9 The metabolic state can be deter-
mined in vivo through the recent advances in microscopy and
the inherent fluorescent properties of NADH, as has been shown
in assessing the viability of excised human skin stored under
various conditions.11, 12
Multiphoton microscopy (MPM) has been utilized for the vi-
sualization of fluorescent molecules within the cell,13 including
measuring the absorption of nanoparticles into human skin.14
MPM enables high-resolution imaging of physiology, morphol-
ogy, and cell-cell interactions in live animals or intact tissue.15
The effective resolution in MPM is far superior to confocal
microscopy because fluorescence only arises from the focus.15
Photodamage in MPM is therefore limited to the focal plane,
however, the possibility of damage in this region still remains.15
Confocal microscopy, however, uses single photon excitation
resulting in broad exposure to high-energy UV and visible
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excitation sources in the specimen above the focus plane, which
could damage photosensitive samples.16 MPM is also better
suited for deep-tissue imaging compared to confocal, because
the infrared light used to generate multiphoton excitation is less
scattered in biological samples.16 This results in a tightly focused
beam with high-photon flux enabling deeper imaging into thick
tissue while restricting photobleaching and phototoxicity.17, 18
The two or more low energy photons in MPM are simultane-
ously absorbed in order to excite an electron from a fluorescent
molecule.19, 20 The photons have similar energies and produce
an excitation equivalent to single-photon absorption possessing
twice the energy.15 The images originate at the beam focus with
no out of focus background present.17
Fluorescence lifetime imaging microscopy (FLIM) is based
on the average time it takes for an electron to return from the
excited state to the ground state. It adds to the information from
MPM by making it possible to resolve multiple lifetimes from
decay data.21 The advantage of FLIM is that it is dependent
on excited state reactions, but independent of the concentration
of the fluorescent molecule.22 The concept of FLIM has been
simply explained by Lakowicz et al. Briefly, the fluorescence in-
tensity cannot reveal any environmental changes, such as protein
binding or pH, but FLIM can.23 Therefore, FLIM provides de-
tails about the structure and dynamics of fluorescent molecules12
and is sensitive to changes in conformation, molecular interac-
tions, ion concentrations, pH9 and oxygen concentrations.24 Our
previous results using MPM-FLIM focused on nanoparticle and
solvent uptake in both excised14, 25–27 and in vivo28, 29 skin. In
addition, this method has been used to study fluorescein distribu-
tion and metabolism in the liver in vivo in rats.14, 30 In the present
study, we utilized the autofluorescent properties of the liver cells
to investigate cellular damage progression in I/R injury.
NADH has fluorescent properties with peak absorption at
350 nm and peak emission of approximately 450 nm.10 The
free and protein-bound forms of NADH have similar excita-
tion and emission wavelengths, but can be separated using their
distinct fluorescence lifetimes of 0.4 to 0.5 and 2.0 to 2.5 ns,
respectively.10 Nicotinamide adenine dinucleotide phosphate
(NADPH) is another reducing agent used in biosynthesis of fatty
acids and steroids. NADH and NADPH have the same excita-
tion and emission wavelengths and fluorescence lifetimes, and
cannot be spectrally resolved.31 Hence, NADH and NADPH
are referred to as NAD(P)H in this paper. However, NADPH
has lower fluorescence intensity, lower concentration, and is
roughly constant with respect to metabolic perturbations com-
pared to NADH.32 The influence of NADPH is therefore con-
sidered very low, although not insignificant. We have previously
studied NAD(P)H in ischemic necrosis of the skin and showed
that MPM-FLIM was useful for noninvasive imaging and to
monitor the metabolic state of the skin.11
Thus, the aim of this study was to investigate whether MPM
and FLIM are useful tools in detecting disease progression in
I/R injury, without the need for external markers.
2 Materials and Methods
2.1 Animals
Male Wistar rats, purchased from the Animal Resource Centre
(Perth, Western Australia), weighing approximately 300 g were
used in all experiments. Studies were approved by the Animal
Ethics Committee of the University of Queensland and were
carried out in accordance with the legislation of Australian au-
thorities for the care and use of experimental animals. Animals
were housed in the Biological Resource Facility at the Princess
Alexandra Hospital, where the temperature is maintained at 20
± 1◦C and humidity at 60 to 75%, with artificial light for 12 h
(7 am to 7 pm) daily. All animals had unlimited access to food
and water.
2.2 Surgical Procedures
Rats were anaesthetized by an initial intraperitoneal injection
of xylazine 10 mg/kg and ketamine hydrochloride 80 mg/kg.
Anaesthesia was maintained throughout the experiment by in-
traperitoneally administering ketamine (2.2 mg/100 g) and xy-
lazine (0.25 mg/100 g). Body temperature was controlled by
placing them on a heated pad set to 37◦C. A midline laparo-
tomy was performed with the left lobe of the liver exposed for
imaging.
2.3 I/R Model
70% ischemia was induced by clamping the portal vein, hep-
atic artery, and bile duct supplying the median and left lobes
of the liver using a microvascular clamp. After 60 min of par-
tial ischemia, the clamp was removed to allow reperfusion in
the liver. Sham rats (controls) underwent the same procedures
without clamping the vessels.
2.4 Tissue Collection
Blood (0.2 ml) was collected from the inferior vena cava using
a 30-gauge needle before ischemia induction and at 2 and 4 h
of reperfusion. After the animal was euthanized at the end of
4 h reperfusion, the left and median lobes were excised, portions
were either snap frozen in liquid nitrogen and stored at − 70◦C
for later analysis of glutathione (GSH), or immersed into 10%
buffered formalin for histological assessment.
2.5 MPM-FLIM
MPM was performed using a DermaInspect system (Jen-
Lab GmbH, Jena, Germany) equipped with an ultrashort (85
femtosecond pulse width) pulsed mode-locked 80-MHz Tita-
nium:Sapphire MaiTai laser (Spectra Physics, Mountain View,
California). For FLIM, a time correlated single photon counting
830 detector (Becker & Hickl, Berlin, Germany) was incor-
porated into the MPM system. The excitation wavelength was
set to 740 nm for FLIM (emission range 350 to 450 nm) and
780 nm for imaging of autofluorescence. For imaging of the
liver, the left lobe was placed on a small metal plate, attached to
an adjustable stand that could be elevated or lowered as required.
The plate was slightly raised above the intraperitoneal cavity to
minimize pressure on the organs underneath. The laser power
was 15 mW and a BG39 (350 to 650 nm) emission filter was
used. The acquisition time for obtaining the images was 13.4 s
per frame. Images were taken pre-ischemia induction, during
ischemia, and at 0, 1, 2, and 4 h of reperfusion.
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2.5.1 Data analysis
FLIM images were analyzed using SPCImage (Becker &
Hickl, Berlin, Germany). Lifetime distributions for NAD(P)H
were obtained by fitting photon count F(t) profiles from each
image to a bi-exponential decay function (F(t) = α1e−t/τ1
+ α2e−t/τ2 ). The reduced chi-square coefficient was used to in-
dicate goodness-of-fit. Two lifetimes, τ 1 and τ 2 represent the
“fast” and “slow” lifetimes of free and protein-bound NAD(P)H,
respectively. The amplitudes α1 and α2 represent the relative
concentration fraction of NAD(P)H, where α1 + α2 = 100.12
The ratio of a1 and a2 is the best way to determine the
free and protein-bound state of NAD(P)H, therefore show-
ing the metabolic changes of the cell. In this study the ac-
tual ratio of α1 and α2 is shown. In addition, the ratio of
α1 and α2 is also presented as pseudo color images exported
from the analyzing software, where a change in color indi-
cates a change in ratio. Actual changes in lifetimes, τ 1 and
τ 2, are not shown in this study. For statistical analysis, stu-
dent t-test for paired samples and one-way ANOVA with
Tukey’s adjustment for multiple comparisons were used. Re-
sults were considered statistically significant with a p-value
≤ 0.05.
2.6 Histopathological Analyses
Staining of haematoxylin and eosin (H&E), ApopTag (for apop-
tosis) and immunohistochemistry for ED1 (for macrophages)
was performed according to standard procedure. Visualization of
ApopTag and ED1 localization was facilitated with diaminoben-
zidine hydrochloride, which stained brown in positively-labeled
cells. Fixed liver was sub-sectioned onto each slide (two to three
sections at 5 μm from different slices of each liver), stained,
and then scanned using an Aperio ScanScope XT slide scan-
ning system (Aperio Technologies Inc., Vista, California) at
20× magnification. The Aperio ImageScope V10.2. software
was used to visualize and score the slides. Severity of tissue
damage was quantified in five areas per slide by two indepen-
dent personnel using a previously described method.33 Three
sets of parameters were studied: a. cellular degeneration defined
as cellular swelling and vacuolation, and reversible changes in
nuclear density; b. infiltration of neutrophils, monocytes, and
macrophages; and c. necrosis defined by cells showing pykno-
sis, karyorrhexis, karyolysis, and cytolysis. These parameters
were graded as follows. Grade 1: no change from normal; Grade
2: a limited number of isolated cells (up to 5% of cells); Grade
3: groups of cells (5 to 30% of the total cell number); and
Grade 4: diffuse cell damage (higher than 30% of the total cell
number). In addition, zonal localization of tissue damage was
recorded.
Using immunohistochemistry for ED1, the number of mono-
cytes and macrophages were identified by counting ED1-
positive cells in the sinusoids in 10 random fields per
slide. Apoptotic cells were identified enzymatically using
ApopTag labeling, and positive nuclei were counted in 10
random fields per region per liver slide. The three differ-
ent regions were 1. periportal (cells surrounding the portal
tract), 2. centrilobular (cells surrounding the central vein), and
3. midzonal (cells between the periportal and centrilobular
zones).
Table 1 Alanine aminotransferase before (pre) and after ischemia in-
duction at 2 and 4 h of reperfusion. [*p < 0.05 versrus sham, #p
< 0.05 versus pre. Mean (± SEM).]
ALT (U/L) ALT (U/L) ALT (U/L)
Pre 2 h 4 h
I/R injury (n = 6) 50 (±5) 1120 (±308)*# 1820 (±600)*#
Sham (n = 4) 40 (±7) 40 (±17) 60 (±20)
2.7 Serum Biochemical Measurements
Plasma concentration of alanine aminotransferase (ALT) was
measured using a Hitachi 747 analyzer (Hitachi Ltd., Tokyo,
Japan) in the Pathology Department at Princess Alexandra
Hospital, Brisbane.
2.8 Determination of Total Glutathione (GSH)
GSH was determined using the Glutathione assay kit (Cayman
Chemical Company). The kit is based on the reaction between
GSH and DTNB [5,5′-dinitro-bis-2-(nitrobenzoic acid)], which
produces a yellow colored TNB (5-thio-2-nitrobenzoic acid).
The production of TNB is directly proportional to the concen-
tration of GSH.
3 Results
3.1 Alanine Transaminase (ALT)
The model of ischemia used resulted in extensive liver dam-
age as measured by increased liver ALT. ALT was significantly
(p < 0.05) increased at 2 (1120 ± 308 U/L) and 4 h (1820
± 600 U/L) of reperfusion compared to sham (Table 1).
3.2 Oxidative Stress
As a measure of oxidative stress, GSH concentration at 4 h
I/R was determined in excised livers. GSH concentration was
significantly (p < 0.05) reduced in the I/R group compared to
sham (Table 2).
3.3 Histopathological Findings
Mild to moderate structural alterations in the liver were found in
the I/R injury group [Fig. 1(a)]. Cellular vacuolation was present
in all sections from the I/R injury group, with scores from 2 to
4 for cell degeneration. Some inflammatory cell infiltration was
Table 2 Levels of oxidative stress were measured by glutathione con-
centration in the liver at 4 h of reperfusion in I/R injury and compared
to sham rats (± SEM). (*p < 0.05 versus sham.)
Glutathione concentration (μmoles/g liver)
I/R injury (n = 6) 1460 (±100)
Sham (n = 5) 550 (±130)*
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Table 3 Semi-quantitative categorization of the morphological injury
parameters in liver tissue after I/R injury. Scoring from 1 to 4, where 1
is no and 4 is a major change (± SEM). (*p < 0.05 versus sham.)
Sham I/R injury
(n = 5) (n = 6)
Cell degeneration 1.1 (±0.08) 2.0 (±0.3)*
Inflammatory cell infiltration
–Neutrophils 1.0 (±0) 1.3 (±0.1) *
–Monocytes/macrophages 1.0 (±0) 1.4 (±0.1)*
Necrosis 1.0 (±0) 1.3 (±0.2)
present in sham and I/R rats at 4 h of reperfusion (Table 3).
There was no statistical difference in the number of monocytes
and macrophages, stained with ED1, as seen in Fig. 1(b). The
number of monocytes and macrophages tended to be slightly
decreased in I/R injury (240 ± 50) compared to the sham group
(310 ± 70), however this was not significantly different.
The number of apoptotic cells was statistically increased in
the centrilobular and midzonal regions compared to the same
regions in the sham group [Fig. 1(c), Table 4] (p < 0.05). There
was a slight increase in the number of apoptotic cells in the
periportal region, however, not statistically significant (Table 4).
3.4 MPM-FLIM
The autofluorescence of the liver in vivo was imaged with high
resolution at 0, 1, 2, and 4 h of reperfusion. Figure 2 shows
representative images from one rat in the I/R injury group and
one in the sham group. A large dark area is seen at 4 h of
reperfusion in the I/R group, which cannot be seen to the same
extent in sham rats (Fig. 2). In addition, vacuoles were formed
within the cells in some of the images taken after ischemia, and
this was not seen in sham rats. Figure 3(a) shows an example of
such a phenomenon at 1 h of reperfusion. The same experiment
was done using a lower magnification objective to visualize the
entire liver acinus. Figure 3(b) shows sample images from one
rat before the start of ischemia (control) and at 4 h of reperfusion.
Dark patches are evident in different areas around the acinus at
4 h of reperfusion that was not seen in the sham group.
FLIM measures the relative contribution of free/bound
NAD(P)H in the liver in vivo in I/R injury. The relative con-
centrations of free (α1) and bound (α2) NAD(P)H were calcu-
lated and plotted against time (Fig. 4). The ratio of free/bound
Table 4 Number of apoptotic cells in the three regions of the liver
lobule. ApopTag-labeled nuclei were counted in 10 different fields per
zone of the liver acinus (mean ± SEM). (*p < 0.05 versus I/R injury,
#p < 0.05 versus periportal and centrilobular.)
Periportal Midzonal Centrilobular
I/R injury (n = 6) 17.8 ± 4.9 89.5 ± 19.5# 43.2 ± 12.8
Sham (n = 5) 7.4 ± 2.5 5.2 ± 1.7* 2.0 ± 0.6*
Fig. 1 Histology of liver tissue after I/R injury. (a) H&E stained liver
tissue shows increased vacuolation in the I/R group. White arrow
indicates vacuoles. (b) ED1 stained liver showing monocytes and
macrophages stained in brown. Black arrows show inflammatory cells.
(c) ApopTag stained liver showing apoptotic cells in the three differ-
ent regions in the liver lobule, periportal, centrilobular, and midzonal.
Black arrows indicate apoptotic cells. Magnification 20×, sham n = 5,
I/R n = 6.
NAD(P)H was significantly increased after 2 and 4 h of reper-
fusion [p < 0.05; Fig. 4(a)]. This increase was due to a statis-
tical increase and decrease in the relative concentration of free
[Fig. 4(b)] and bound [Fig. 4(c)] NAD(P)H, respectively.
Another way of showing the relative concentration of
free/bound NAD(P)H is to false color the images obtained from
the FLIM analysis. Figure 4(d) shows sample images from one
rat in the I/R injury group and another from the sham group.
The color of the images (from blue to red) indicates the ratio of
free/bound NAD(P)H. At 1, 2, and 4 h of reperfusion there is a
shift in the color to yellow, indicating an increase in the ratio as
seen in the color bar.
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Fig. 2 Multiphoton microscopy images of liver in vivo in I/R injury at various reperfusion time points compared to sham rats. The white arrow
indicates a large dark area not seen in the sham group.
4 Discussion
Fluorescence microscopy can provide valuable information
on tissue morphology without the need for histological
assessment.34 The technique utilizes the autofluorescence
Fig. 3 Multiphoton microscopy images of liver tissue on cellular and
acinus levels. (a) Images recorded at 1 h of reperfusion in the I/R group
using high and (b) at 4 h using low magnifications (40× and 10×,
respectively). White opened arrow indicates vacuolation and solid ar-
rows indicate increased dark areas.
of tissue components such as NADH,34 flavine adenine
dinucleotide,35 and other flavoproteins.36 However, most pre-
vious studies have been conducted in vitro with only a few
studies performed on live animals.34 External markers for liver
damage such as rhodamine 123 and propidium iodide have pre-
viously been used to study mitochondrial permeability transition
and necrosis, respectively.37, 38 However, the aims of this study
were to investigate whether we could use the autofluorescent
properties of the tissue to detect cell damage using MPM in
combination with FLIM. MPM uses a high-pulsed laser, which
provides low average energy received by the sample imaged.39 In
addition, MPM restricts excitation of a fluorescent molecule to
the focal plane of the microscope.39 Consequently, MPM signif-
icantly improves the quality of images acquired from biological
tissue, by reducing photodamage and photobleaching of tissue
compared to conventional fluorescence microscopy.17, 19, 20
The model of ischemia used resulted in extensive liver dam-
age, as measured by increased liver ALT (Table 1) and depletion
of one of the cellular defence mechanisms against free radi-
cals (GSH) (Table 2). Early ischemia reperfusion injury has in
previous studies resulted in similar increases of ALT and GSH
levels.40, 41 It has been shown that this injury is mediated through
a release in free radicals both within the cell and outside through
Kupffer cell activation.42
It was evident that hepatocytes became vacuolated after 1 h
of reperfusion, indicating cellular stress43 that was not evident
in sham rats [Fig. 3(a)]. In addition to the fluorescence inten-
sity images, traditional H&E staining of the liver also showed
vacuolation in the hepatocytes [Fig. 1(a)], which confirms the
findings of Sireli et al., who reported swollen hepatocytes with
vacuolated cytoplasm during I/R injury.44 Additional immuno-
histological staining for monocytes and macrophages showed
no increase in the number of these inflammatory cells in the I/R
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Fig. 4 Changes in free and bound levels of NAD(P)H recorded by fluorescence lifetime imaging microscopy. (a) Ratio of free/bound NAD(P)H was
significantly increased at 2 and 4 h of reperfusion in the I/R group compared to sham. This increase was shown to be due to an increase in (b)
free NAD(P)H and a decrease in (c) bound NAD(P)H, respectively. (d) Relative concentration of free/bound NAD(P)H is expressed in pseudo color
images. The color of the cells in I/R injury shifts toward yellow over time indicating an increase in the ratio of free/bound NAD(P)H. This increase
was not seen in sham rats. *p < 0.05 versus sham (n = 4).
injury group. Since the liver has its own macrophages, called
Kupffer cells, that line the sinusoids, it is probable that ED1
would stain those as well.45 The number of Kupffer cells should
stay constant in the liver, which would explain why the num-
ber of stained monocytes and macrophages are similar in both
groups.45
In the images recorded by MPM, large dark areas were no-
ticed at 4 h of reperfusion in the I/R injury group that could not be
seen in any of the sham rats. A decrease in fluorescence is most
likely due to a decrease in NAD(P)H fluorescence, which oc-
curs in cell death.46 Using high magnification, this dark area was
seen in three out of four I/R animals. We, therefore, suspected a
zonal spread in the liver damage and investigated this at lower
magnification. While the results showed variation in intensity of
light and dark, the dark areas of the liver were localized away
from the periportal region. To confirm the heterogenic spread in
the damage the harvested livers were histopathologically ana-
lyzed. ApopTag stained cells, staining DNA damaged nuclei,47
were significantly increased in the centrilobular and midzonal
regions, but not in the periportal region. Early ischemia reper-
fusion injury induces a burst of free radicals,42 which in turn
cause DNA strand breaks in the nuclei of the cells. Although
the strand breaks may predetermine progress to apoptosis, they
may also be repairable and so the injury is reversible. Apop-
Tag enzymatic labeling, by its very nature,48 will label both
repairable and apoptosis-inducing DNA strand breaks. The nu-
clei that stained positive with the ApopTag as shown in Fig. 1(c),
but had apparently normal structure after the (4 h) reperfusion,
may ultimately take either pathway. Our group is now focusing
on the long term damage of hepatic I/R injury. A review of the
literature suggests that there is an altered distribution of zonal
damage associated with different liver diseases. For example,
hypoxia and free radical production have been reported to affect
cells around the central vein in alcohol induced liver injury,49
whereas midzonal parenchymal cells were more susceptible to
oxidative stress in cancer and cirrhosis.50 Furthermore, liver
damage was more pronounced in centrilobular and midzonal
regions after acetaminophen administration.51
The brighter parts of the images are likely explained by an
increase in NAD(P)H concentration during I/R injury. Barbiro
et al. showed a significant increase in NADH levels in hepatic
I/R injury,52 and similar results have been reported in hypoxic
hepatocytes in vitro.53 NADH loses fluorescence during oxida-
tion to NAD(P) + , thus NAD(P)H fluorescence can be used to
monitor metabolism.54 However, measuring total concentration
of NAD(P)H can be misleading because it is not possible to know
whether the fluorescence is derived from free or protein-bound
NAD(P)H.32 FLIM is, therefore, a better probe for studying
changes in NAD(P)H because the lifetime of the molecule is
significantly enhanced with binding.32 The amplitude (α) can
be related to the concentration of NAD(P)H9, 54, 55 and the ratio
of free/bound (α1/ α2) NAD(P)H was calculated at different
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reperfusion time points. A significant increase was seen at 2 and
4 h of reperfusion [Figs. 4(a) and 4(d)]. This was attributed to an
increase in free and a decrease in bound NAD(P)H [Figs. 4(b)
and 4(c)]. It is possible that the increase in free/bound NAD(P)H
seen in this study is attributable to the Pasteur effect, where
cellular respiration is shifted to glycolysis, producing ATP in
anaerobic conditions.56, 57 An increase in glycolysis leads to
an increase in lactic acid production,35 which was previously
reported in pig liver during warm ischemia.58 In addition, in-
creased levels of lactic acid were seen in patients undergoing
hepatectomy, which further coincides with the theory of shift to
glycolysis in I/R injury of the liver.59 Our group has previously
shown an increase in free NAD(P)H in skin after zinc oxide
application in vivo.28
In conclusion, liver damage associated with I/R injury, with
up to 4 h of reperfusion, was structurally characterized by a
zonal distribution of vacuolated and degenerating hepatocytes,
increased apoptosis, and mild necrosis. The damage was mainly
localized in the midzonal region. MPM was able to detect both
cellular degeneration and the zonal spread of damage, by show-
ing irregular fluorescence intensity of the hepatocytes. FLIM
added to these results by detecting changes in cellular respi-
ration, which was attributed by an increase in free NAD(P)H
and a decrease in bound NAD(P)H in I/R injury. This is an im-
portant and novel finding in that it allows us to follow disease
development without the administration of an external marker
in vivo.
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